BuzzSparks.org

TargeGen


TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation. The company offers its...

Founded in 2002
Homepage:

92121 9380 Judicial Drive

San Diego
USA CA

Phone: 858-678-0760

Updated on Aug 12, 2011
TargeGen at CrunchBase
Wood C. Erwin CFO
Arda Minocherhomjee Director
Drew Senyei Board of Directors
Past
Peter G. Ulrich Co-Founder, President & CEO
Glenn Noronha

June, 2010

TargeGen was acquired by Sanofi Aventis
for $635M

On a spree, Sanofi scoops up TargeGen in $635M dea Read more: On a spree, Sanofi scoops up TargeGen in $635M deal    fiercebiotech.com

2002

TargeGen was founded in 2002